Titre : Inositol phosphates

Inositol phosphates : Questions médicales fréquentes

Termes MeSH sélectionnés :

Visual Field Tests
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Inositol phosphates : Questions médicales les plus fréquentes", "headline": "Inositol phosphates : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Inositol phosphates : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-23", "dateModified": "2025-04-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Inositol phosphates" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Oses phosphates", "url": "https://questionsmedicales.fr/mesh/D013403", "about": { "@type": "MedicalCondition", "name": "Oses phosphates", "code": { "@type": "MedicalCode", "code": "D013403", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D09.894" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inositol 1,4,5-trisphosphate", "alternateName": "Inositol 1,4,5-Trisphosphate", "url": "https://questionsmedicales.fr/mesh/D015544", "about": { "@type": "MedicalCondition", "name": "Inositol 1,4,5-trisphosphate", "code": { "@type": "MedicalCode", "code": "D015544", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D09.894.480.350" } } }, { "@type": "MedicalWebPage", "name": "Acide phytique", "alternateName": "Phytic Acid", "url": "https://questionsmedicales.fr/mesh/D010833", "about": { "@type": "MedicalCondition", "name": "Acide phytique", "code": { "@type": "MedicalCode", "code": "D010833", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D09.894.480.700" } } } ], "about": { "@type": "MedicalCondition", "name": "Inositol phosphates", "alternateName": "Inositol Phosphates", "code": { "@type": "MedicalCode", "code": "D007295", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Adolfo Saiardi", "url": "https://questionsmedicales.fr/author/Adolfo%20Saiardi", "affiliation": { "@type": "Organization", "name": "Medical Research Council Laboratory for Molecular Cell Biology, University College London, WC1E6BT, London, UK. Electronic address: a.saiardi@ucl.ac.uk." } }, { "@type": "Person", "name": "Henning J Jessen", "url": "https://questionsmedicales.fr/author/Henning%20J%20Jessen", "affiliation": { "@type": "Organization", "name": "Institute of Organic Chemistry & CIBSS - Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany." } }, { "@type": "Person", "name": "Gabriel Schaaf", "url": "https://questionsmedicales.fr/author/Gabriel%20Schaaf", "affiliation": { "@type": "Organization", "name": "Department of Plant Nutrition, Institute of Crop Science and Resource Conservation, Rheinische Friedrich-Wilhelms-University Bonn, Bonn, Germany. gabriel.schaaf@uni-bonn.de." } }, { "@type": "Person", "name": "Debabrata Laha", "url": "https://questionsmedicales.fr/author/Debabrata%20Laha", "affiliation": { "@type": "Organization", "name": "Medical Research Council Laboratory for Molecular Cell Biology, University College London, WC1E6BT, London, UK." } }, { "@type": "Person", "name": "Stephen B Shears", "url": "https://questionsmedicales.fr/author/Stephen%20B%20Shears", "affiliation": { "@type": "Organization", "name": "Inositol Signaling Section, NIEHS, 111, Alexander Drive, Research Triangle Park, Durham, NC 27709, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Progressive Paracentral Visual Field Loss at Low Intraocular Pressures Following LASIK.", "datePublished": "2024-06-14", "url": "https://questionsmedicales.fr/article/39141409", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/IJG.0000000000002395" } }, { "@type": "ScholarlyArticle", "name": "Smoking Cessation May Reduce Risk of Visual Field Progression in Heavy Smokers.", "datePublished": "2022-08-02", "url": "https://questionsmedicales.fr/article/35939832", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/IJG.0000000000002092" } }, { "@type": "ScholarlyArticle", "name": "Correlation between Interocular Asymmetry of Corneal Hysteresis and Visual Field Defect in Glaucoma.", "datePublished": "2023-02-09", "url": "https://questionsmedicales.fr/article/36758563", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3341/kjo.2022.0120" } }, { "@type": "ScholarlyArticle", "name": "Comparing the Accuracy of Peripapillary OCT Scans and Visual Fields to Detect Glaucoma Worsening.", "datePublished": "2023-02-06", "url": "https://questionsmedicales.fr/article/36754173", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ophtha.2023.01.021" } }, { "@type": "ScholarlyArticle", "name": "Two-Year Visual Field Outcomes of the Treatment of Advanced Glaucoma Study (TAGS).", "datePublished": "2022-10-10", "url": "https://questionsmedicales.fr/article/36228777", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ajo.2022.09.011" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Glucides", "item": "https://questionsmedicales.fr/mesh/D002241" }, { "@type": "ListItem", "position": 3, "name": "Oses phosphates", "item": "https://questionsmedicales.fr/mesh/D013403" }, { "@type": "ListItem", "position": 4, "name": "Inositol phosphates", "item": "https://questionsmedicales.fr/mesh/D007295" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Inositol phosphates - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Inositol phosphates", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Inositol phosphates", "description": "Comment diagnostiquer un déséquilibre en inositol phosphates ?\nQuels tests sont utilisés pour évaluer les inositol phosphates ?\nLes inositol phosphates sont-ils mesurables dans les tissus ?\nY a-t-il des marqueurs spécifiques pour les inositol phosphates ?\nLes tests génétiques sont-ils utiles pour les inositol phosphates ?", "url": "https://questionsmedicales.fr/mesh/D007295?mesh_terms=Visual+Field+Tests&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Inositol phosphates", "description": "Quels symptômes sont associés à un déséquilibre en inositol phosphates ?\nLes inositol phosphates affectent-ils la santé mentale ?\nY a-t-il des signes physiques d'un déséquilibre ?\nLes inositol phosphates influencent-ils le métabolisme ?\nPeut-on observer des symptômes neurologiques ?", "url": "https://questionsmedicales.fr/mesh/D007295?mesh_terms=Visual+Field+Tests&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Inositol phosphates", "description": "Comment prévenir les déséquilibres en inositol phosphates ?\nLes suppléments sont-ils nécessaires pour la prévention ?\nY a-t-il des habitudes de vie à adopter ?\nLes consultations médicales sont-elles importantes ?\nLes facteurs environnementaux influencent-ils les niveaux ?", "url": "https://questionsmedicales.fr/mesh/D007295?mesh_terms=Visual+Field+Tests&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Inositol phosphates", "description": "Quels traitements existent pour les déséquilibres en inositol phosphates ?\nLes médicaments peuvent-ils aider avec les inositol phosphates ?\nY a-t-il des thérapies alternatives pour les inositol phosphates ?\nComment les changements alimentaires aident-ils ?\nLes traitements sont-ils personnalisés ?", "url": "https://questionsmedicales.fr/mesh/D007295?mesh_terms=Visual+Field+Tests&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Inositol phosphates", "description": "Quelles complications peuvent survenir avec des déséquilibres ?\nLes inositol phosphates sont-ils liés à des maladies chroniques ?\nY a-t-il des risques pour la santé reproductive ?\nLes complications neurologiques sont-elles fréquentes ?\nLes complications psychologiques sont-elles réversibles ?", "url": "https://questionsmedicales.fr/mesh/D007295?mesh_terms=Visual+Field+Tests&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Inositol phosphates", "description": "Quels sont les facteurs de risque pour les déséquilibres ?\nL'âge influence-t-il les niveaux d'inositol phosphates ?\nLes maladies métaboliques sont-elles un facteur de risque ?\nLe mode de vie sédentaire est-il un risque ?\nLes facteurs environnementaux jouent-ils un rôle ?", "url": "https://questionsmedicales.fr/mesh/D007295?mesh_terms=Visual+Field+Tests&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un déséquilibre en inositol phosphates ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins peuvent mesurer les niveaux d'inositol phosphates dans le corps." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les inositol phosphates ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests biochimiques et les analyses de métabolites urinaires sont courants." } }, { "@type": "Question", "name": "Les inositol phosphates sont-ils mesurables dans les tissus ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des biopsies peuvent être effectuées pour évaluer les niveaux dans les tissus." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs spécifiques pour les inositol phosphates ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs comme l'IP3 peuvent indiquer des déséquilibres dans la signalisation cellulaire." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils utiles pour les inositol phosphates ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent aider à identifier des troubles métaboliques liés aux inositol phosphates." } }, { "@type": "Question", "name": "Quels symptômes sont associés à un déséquilibre en inositol phosphates ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, troubles de l'humeur et problèmes métaboliques peuvent survenir." } }, { "@type": "Question", "name": "Les inositol phosphates affectent-ils la santé mentale ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des déséquilibres peuvent être liés à des troubles de l'humeur comme la dépression." } }, { "@type": "Question", "name": "Y a-t-il des signes physiques d'un déséquilibre ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des troubles de la peau ou des problèmes digestifs peuvent apparaître." } }, { "@type": "Question", "name": "Les inositol phosphates influencent-ils le métabolisme ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils jouent un rôle dans la régulation du métabolisme lipidique et glucidique." } }, { "@type": "Question", "name": "Peut-on observer des symptômes neurologiques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles cognitifs et de la mémoire peuvent être liés à des déséquilibres." } }, { "@type": "Question", "name": "Comment prévenir les déséquilibres en inositol phosphates ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et un mode de vie sain sont essentiels pour la prévention." } }, { "@type": "Question", "name": "Les suppléments sont-ils nécessaires pour la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments peuvent être bénéfiques, surtout en cas de carence alimentaire." } }, { "@type": "Question", "name": "Y a-t-il des habitudes de vie à adopter ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "L'exercice régulier et la gestion du stress peuvent aider à maintenir l'équilibre." } }, { "@type": "Question", "name": "Les consultations médicales sont-elles importantes ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des bilans réguliers peuvent aider à détecter des déséquilibres précocement." } }, { "@type": "Question", "name": "Les facteurs environnementaux influencent-ils les niveaux ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines peut affecter le métabolisme des inositol phosphates." } }, { "@type": "Question", "name": "Quels traitements existent pour les déséquilibres en inositol phosphates ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments d'inositol et des modifications alimentaires peuvent être recommandés." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider avec les inositol phosphates ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments psychotropes peuvent influencer les niveaux d'inositol phosphates." } }, { "@type": "Question", "name": "Y a-t-il des thérapies alternatives pour les inositol phosphates ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des approches comme la phytothérapie peuvent être explorées, mais nécessitent des études." } }, { "@type": "Question", "name": "Comment les changements alimentaires aident-ils ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en fruits et légumes peut améliorer les niveaux d'inositol." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent être adaptés selon les besoins individuels et les symptômes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des déséquilibres ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles métaboliques, neurologiques et psychologiques peuvent se développer." } }, { "@type": "Question", "name": "Les inositol phosphates sont-ils liés à des maladies chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des déséquilibres peuvent être associés à des maladies comme le diabète." } }, { "@type": "Question", "name": "Y a-t-il des risques pour la santé reproductive ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des déséquilibres peuvent affecter la fertilité et la santé reproductive." } }, { "@type": "Question", "name": "Les complications neurologiques sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles cognitifs peuvent survenir en cas de déséquilibre prolongé." } }, { "@type": "Question", "name": "Les complications psychologiques sont-elles réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines peuvent être réversibles avec un traitement approprié et un suivi." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les déséquilibres ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation pauvre, le stress et des antécédents familiaux peuvent augmenter le risque." } }, { "@type": "Question", "name": "L'âge influence-t-il les niveaux d'inositol phosphates ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les niveaux peuvent diminuer avec l'âge, augmentant le risque de déséquilibre." } }, { "@type": "Question", "name": "Les maladies métaboliques sont-elles un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des conditions comme le diabète peuvent affecter le métabolisme des inositol phosphates." } }, { "@type": "Question", "name": "Le mode de vie sédentaire est-il un risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie inactif peut contribuer à des déséquilibres en inositol phosphates." } }, { "@type": "Question", "name": "Les facteurs environnementaux jouent-ils un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines peut perturber le métabolisme des inositol phosphates." } } ] } ] }

Sources (10000 au total)

Smoking Cessation May Reduce Risk of Visual Field Progression in Heavy Smokers.

The earlier a person quits smoking the more likely is the optic nerve be spared from damage.... To investigate the effect of smoking cessation on visual field (VF) progression in glaucoma.... Primary open angle glaucoma patients with a minimum of 3 years follow-up and 5 VFs were included. Linear mixed models were used to investigate the effects of smoking on the rates of 24-2 VF mean devia... Five hundred eleven eyes of 354 patients were included over the mean follow-up of 12.4 years. Mean baseline age (95% confidence interval) was 62.3 (61.2, 63.4) years. One hundred forty nine (42.1%) pa... After ≥25 years of smoking cessation, the risk of VF progression in former heavy smokers becomes similar to never smokers. Long-term smoking cessation may be associated with lower VF progression in gl...

Correlation between Interocular Asymmetry of Corneal Hysteresis and Visual Field Defect in Glaucoma.

To evaluate the relationship between interocular asymmetries of corneal hysteresis (CH) and visual field defects in Korean patients with glaucoma.... A total of 444 eyes from 222 participants with glaucoma in at least one eye were enrolled. CH was measured using an ocular response analyzer (Reichert Technologies Inc). Eyes of each participant were ... Median (interquartile range) MD value was -3.71 dB (-6.87 to -1.30 dB) in the better eye and -10.20 dB (-16.32 to -5.62 dB) in the worse eye. When the correlation between the asymmetry of the MD value... The interocular asymmetry of CH was significantly correlated with the interocular asymmetry of visual field defects in glaucoma....

Comparing the Accuracy of Peripapillary OCT Scans and Visual Fields to Detect Glaucoma Worsening.

To compare the accuracy of detecting moderate and rapid rates of glaucoma worsening over a 2-year period with different numbers of OCT scans and visual field (VF) tests in a large sample of glaucoma a... Descriptive and simulation study.... The OCT sample comprised 12 150 eyes from 7392 adults with glaucoma or glaucoma suspect status followed up at the Wilmer Eye Institute from 2013 through 2021. The VF sample comprised 20 583 eyes from ... Within-eye rates of change in retinal nerve fiber layer (RNFL) thickness and mean deviation (MD) were measured using linear regression. For each measured rate, simulated measurements of RNFL thickness... The accuracy of diagnosing moderate and rapid rates of glaucoma worsening for different numbers of OCT scans and VF tests over a 2-year period.... Accuracy was less than 50% for both OCT and VF when diagnosing worsening after a 2-year period. OCT accuracy was 5 to 10 percentage points higher than VF accuracy at detecting moderate worsening and 1... More frequent OCT scans and VF tests are needed to improve the accuracy of diagnosing glaucoma worsening. Accuracy greatly increases when relying on both OCT and VF to detect worsening.... The author(s) have no proprietary or commercial interest in any materials discussed in this article....

Two-Year Visual Field Outcomes of the Treatment of Advanced Glaucoma Study (TAGS).

to compare visual field (VF) progression between the 2 arms of the Treatment of Advanced Glaucoma Study (TAGS).... Post hoc analysis of VF data from a 2-arm, multicenter, randomized controlled clinical trial.... A total of 453 patients with newly diagnosed advanced open-angle glaucoma in at least 1 eye from 27 centers in the United Kingdom were randomized to either trabeculectomy (n = 227) or medication in th... This study analyzed 211 eyes in the trabeculectomy first arm and 203 eyes in the medication first arm. The average RoP (estimate [95% credible intervals]) was -0.59 [-0.88, -0.31] dB/year in the medic... There was no significant difference in the average RoP at 2 years....

Visual Field Endpoints for Neuroprotective Trials: A Case for AI-Driven Patient Enrichment.

To evaluate whether an artificial intelligence (AI) model can better select candidates that would demonstrate visual field (VF) progression, in order to shorten the duration or the number of patients ... Retrospective cohort study.... 7428 eyes of 3871 patients from the University of Washington Department of Ophthalmology VF Dataset were included. Progression was defined as at least 5 locations with >7 dB of change compared with ba... A total of 13% of all patients met the criteria for progression at 5 years. Differences in survival were observed when stratified by MD and age (P < .0001). Those at risk of progression included patie... An AI model can identify high-risk patients to substantially reduce the number of patients needed or study duration required to meet clinical trial endpoints....

Fast Progressors in Glaucoma: Prevalence Based on Global and Central Visual Field Loss.

To determine the prevalence of fast global and central visual field (VF) progression in individuals with glaucoma under routine care.... Observational study.... Six hundred ninety-three eyes of 461 individuals with glaucoma followed up over a median of 4.5 years.... This study included (1) patients at a private ophthalmology clinic in Melbourne, Australia, and (2) individuals in 2 prospective longitudinal observational studies across 3 sites in the United States.... Prevalence of progression based on the rate of MD and the MTD... Based on the MD and the MTD... This study found that approximately 1 in 8 eyes with glaucoma receiving routine care showed fast progression based on global MD values (< -1.0 dB/year) and that nearly 1 in 3 eyes showed a < -0.5 dB/y... Proprietary or commercial disclosure may be found after the references....

Accuracy of Visual Fields in Localizing MRI Lesions in Posterior Cerebral Artery Infarction.

The representation of the visual field in visual cortex was established over a century ago by correlating perimetric defects with the estimated location of war wounds. The availability of high-definit... Homonymous hemianopias disclosed on automated visual fields (HVFs) were drawn from an electronic medical record search from 2009 to 2020 at the Michigan Medicine, a tertiary care academic medical cent... Among the 77 VFDs confined to 1 hemifield, 74 (96%) correctly predicted the side of the visual cortex lesion. In 3 cases, the MRI lesion in the opposite cerebral hemisphere was not foretold. Among the... In this study of PCA ischemic stroke, VFDs limited to 1 hemifield were accurate in locating the side and quadrant of the MRI visual cortex lesions. However, the quadrantic VFDs sometimes failed to pre...

Baseline 10-2 Visual Field Loss as a Predictor for Future Glaucoma Progression.

Presence of baseline 10-2 visual field (VF) loss was the strongest predictor of future rate of 24-2 VF loss and development of new 24-2 progression events, suggesting a role for 10-2 VF testing in bas... The purpose of this study is to examine the relationship between baseline 10-2 VF loss and future 24-2 VF loss.... Subjects were participating in a prospective longitudinal study within a VA Medical Center outpatient eye clinic. Eligibility required 2 good quality baseline 10-2 VF tests followed by a minimum of 5 ... We studied 394 eyes of 202 subjects (119 primary open angle glaucoma and 83 glaucoma suspect). Over 6.7 (±1.5) years, 9.9 (±2.3) good quality 24-2 VF tests were completed. In mixed model regression an... Baseline 10-2 VF defect was the most effective predictor of subsequent 24-2 VF progression in this study. These findings imply that presence of baseline 10-2 VF loss may provide unique value for predi...